Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
08/2003
08/13/2003CN1436185A Thrombin receptor antagonists
08/13/2003CN1436175A Cyclic lactams as inhibitors of A beta-protein production
08/13/2003CN1436174A HMG-CoA reductase inhibitors and their use as medicaments for treatment of cholesterol related diseases
08/13/2003CN1436172A 1,2-dihydropyridine compounds, process for preparation of same and use thereof
08/13/2003CN1436086A Interferon for treatment of multiple sclerosis
08/13/2003CN1436085A Method for treating pain by peripheral administration of neurotoxin
08/13/2003CN1436080A Use of cyclic-GMP-specific phosphodiesterase inhibitor for treating parkinson's disease
08/13/2003CN1436078A Use of (+)-alpha-(2,3-dimethoxyphenyl)1-ÒÇö2-(4-fluorophenyl) ethylÒÇò-4-piperidinemethanol or its prodrug in treatment of symptoms of dementia and dopamine induced psychosis
08/13/2003CN1436076A Method of treating cardiovascular disease
08/13/2003CN1436075A Gabapentin analogues for sleep disorders
08/13/2003CN1436074A Remedies
08/13/2003CN1436048A Infant formulas contg. long-chain polyunsaturated fatty acids and uses thereof
08/13/2003CN1435238A Chinese medicine powder for treating brain atrophy disease
08/13/2003CN1435214A Compound body-strengthening eucommia bark mixture for treating diseases caused by kidney Qi deficiency
08/13/2003CN1435213A Chinese medicine preparation ÔÇ£Tianlongdanhua capsuleÔÇØ"
08/13/2003CN1435206A Sedative jujube kernel capsule
08/13/2003CN1435187A Neural stem cell preparation, preparing method thereof and use of same
08/13/2003CN1435186A Use of refined fur seal oil for preparing medicine for preventing and treating senile dementia and apoplexy sequela
08/13/2003CN1117755C Spiroazabicyclic heterocyclic compounds, method for preparing same and use thereof
08/13/2003CN1117738C Endothelin antagonists
08/13/2003CN1117575C Drug-dropping Chinese patent medicine for improving immunity of human body itself
08/13/2003CN1117567C Paroxetine controlled release compositions
08/13/2003CN1117564C Use of prumipexole in treating of restless legs syndrome
08/13/2003CN1117562C Compositions and method for controlling smoking
08/12/2003US6605729 Crystalline forms of [R-(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid calcium salt (2:1)
08/12/2003US6605725 Treating a central or peripheral nervous system disorder or condition through modulation of a voltage-dependent potassium channel
08/12/2003US6605723 Process for the preparation of ethanesul fonyl-piperidine derivatives
08/12/2003US6605642 Inhibitors of formation of advanced glycation endproducts (AGES)
08/12/2003US6605637 Lipoic acid derivatives, their preparation, and pharmaceutical compositions containing them
08/12/2003US6605634 Aryl and heteroaryl substituted fused pyrrole anti-inflammatory agents
08/12/2003US6605633 Such as 5-Bromo-2-phenyl-1H-indole-3-butanoic acid
08/12/2003US6605632 Affinity for melatonin receptors
08/12/2003US6605629 Oxazole derivatives; low toxicity
08/12/2003US6605621 Monomeric and dimeric heterocycles, and therapeutic uses thereof
08/12/2003US6605610 Aryl fused azapolycyclic compounds
08/12/2003US6605607 Antihypertensives; hyperprolactinaemia related conditions; certain central nervous system disorders
08/12/2003US6605600 Diuretics
08/12/2003US6605597 Partial or full A1agonists-N-6 heterocyclic 5′-thio substituted adenosine derivatives
08/12/2003US6605592 Protein HOFNF53
08/12/2003US6605300 Oral pulsed dose drug delivery system
08/12/2003US6605255 Kit comprising a pharmaceutical composition containing repinotan or a physiologically acceptable salt of repinotan, and a means for the determination of the concentration of repinotan or its metabolites in body
08/12/2003CA2418712A1 Non-peptide gnrh agents, pharmaceutical compositions, and methods for their use
08/12/2003CA2360303C Process for the preparation of pure citalopram
08/12/2003CA2212836C Substituted isoxazoles for the treatment of inflammation
08/12/2003CA2088702C Aminobenzoic acid derivatives
08/08/2003WO2002060922A2 Epoxyvibsanin b
08/08/2003CA2458220A1 Epoxyvibsanin b
08/08/2003CA2417305A1 Method of affecting sleep & sleep-related behaviours
08/07/2003WO2003065046A2 Diagnostics and therapeutics for diseases associated with a new human 5-ht6 receptor
08/07/2003WO2003065044A2 Diagnostics and therapeutics for diseases associated with gpr72
08/07/2003WO2003064685A2 Genetic polymorphisms in the preprotachykinin gene
08/07/2003WO2003064647A1 Method of controlling circadian rhythm
08/07/2003WO2003064646A1 Novel peptide and use thereof
08/07/2003WO2003064629A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
08/07/2003WO2003064622A2 Aggrecanase molecules
08/07/2003WO2003064596A2 Desaturase genes, enzymes encoded thereby, and uses thereof
08/07/2003WO2003064472A2 Treatment of ms with goat serum
08/07/2003WO2003064464A1 Tolerogenic peptides from myelin basic protein
08/07/2003WO2003064447A2 Immune-modulating peptide
08/07/2003WO2003064443A2 New corticosteroids
08/07/2003WO2003064429A1 Thienopyrimidines, process for preparing the same and use thereof
08/07/2003WO2003064428A1 Furano- and thienopyrimidines as neurokinase inhibitors
08/07/2003WO2003064425A1 N-substituted spiropiperidine compounds as ligands for orl-1 receptor
08/07/2003WO2003064423A1 Aza-arylpiperazines
08/07/2003WO2003064419A1 Novel fluorene carboxylic acid esters, methods for the production thereof, and use of the same as pharmaceuticals
08/07/2003WO2003064418A1 Anticholinergic agents, method for producing the same and use thereof as medicaments
08/07/2003WO2003064411A1 Amides of aminoalkyl-substituted azetidines, pyrrolidines, piperidines and azepanes
08/07/2003WO2003064405A1 Drechslera anole derivatives, method for the production and use thereof
08/07/2003WO2003064397A1 Indazole compounds useful as protein kinase inhibitors
08/07/2003WO2003064395A1 Preventive or therapeutic agents for neurodegenerative diseases
08/07/2003WO2003064393A1 Thio-carbostyril derivative, its n-oxides and the n-oxides of aripiprazole
08/07/2003WO2003064387A2 Substituted indoles as alpha-1 agonists
08/07/2003WO2003064383A2 Phosphorus-containing compounds & uses thereof
08/07/2003WO2003064375A1 New opioid derivative
08/07/2003WO2003064372A1 2-adamantylalkylamines and their use in the treatment of conditions generally associated with abnormalities in glutamatergic transmission
08/07/2003WO2003064369A1 Novel thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof
08/07/2003WO2003063907A1 Drugs ameliorating circadian rhythum disorder
08/07/2003WO2003063905A1 Preventives or remedies for immunological diseases
08/07/2003WO2003063892A1 Use of apelin
08/07/2003WO2003063891A1 Compositions and methods for modulating connexin hemichannels
08/07/2003WO2003063884A1 A herbal pharmaceutical composition for treating siriasis and its process
08/07/2003WO2003063880A1 Disruption of islet amyloid by polycyclic compounds
08/07/2003WO2003063876A2 Methods of treating patients suffering from movement disorders
08/07/2003WO2003063874A1 Condensed heterocyclic compounds
08/07/2003WO2003063872A1 Non-sedating barbituric acid derivatives
08/07/2003WO2003063862A1 Cotherapy with an oxazolidinone and a vitamin b
08/07/2003WO2003063859A1 Suppression of cartilage degradation via the estrogen receptor
08/07/2003WO2003063857A1 A novel dosage form of l-methionine s-sulfoximine
08/07/2003WO2003063850A1 Medicinal compositions containing vitamin k’s as nerve growth factor potentiator and utilization thereof
08/07/2003WO2003063846A2 Aldosterone receptor antagonist and alpha-adrenergic modulating agent combination therapy for prevention or treatment of cardiovascular conditions
08/07/2003WO2003063830A1 Method for increasing the water-solubility of lipophilic, active substances, production of highly concentrated aqueous compositions of said active substances, corresponding products and their use
08/07/2003WO2003063800A2 8-heteroaryl xanthine adenosine a2b receptor antagonists
08/07/2003WO2003063779A2 Selective analgesic agents
08/07/2003WO2003063766A2 Novel immunogenic compositions for the prevention and treatment of meningococcal disease
08/07/2003WO2003063760A2 Peptides antibodies directed thereagainst and methods using same for diagnosing and treating amyloid-associated diseases
08/07/2003WO2003063758A2 Bicyclic cb2 cannabinoid receptor ligands
08/07/2003WO2003063585A1 Animal model
08/07/2003WO2003063573A2 Method for treating diseases with omega interferon
08/07/2003WO2003030886A3 Allylamides useful in the treatment of alzheimer's disease
08/07/2003WO2003028662A3 A method of producing a processed kava product having an altered kavalactone distribution and processed kava products produced using the same
1 ... 1185 1186 1187 1188 1189 1190 1191 1192 1193 1194 1195 1196 1197 1198 1199 1200 1201 1202 1203 1204 1205 ... 1833